US Stock MarketDetailed Quotes

IMUX Immunic

Watchlist
  • 1.040
  • -0.030-2.80%
Trading Nov 19 11:49 ET
93.68MMarket Cap-845P/E (TTM)

About Immunic Company

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.

Company Profile

SymbolIMUX
Company NameImmunic
Listing DateApr 17, 2014
Issue Price12.00
Founded2003
CEODr. Daniel Vitt, PhD
MarketNASDAQ
Employees77
Fiscal Year Ends12-31
Address1200 Avenue of the Americas,Suite 200
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-332-255-9818
Websitehttp://imux.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Daniel Vitt, PhD
  • Director and Chief Executive Officer
  • 1.21M
  • Jason Tardio, M.B.A.
  • Chief Operating Officer and President
  • --
  • Dr. Hella Kohlhof
  • Chief Scientific Officer
  • --
  • Dr. Andreas Muehler
  • Chief Medical Officer
  • 845.29K
  • Glenn Whaley
  • Chief Financial Officer
  • 702.21K
  • Werner Gladdines
  • Chief Development Officer
  • --
  • Patrick Walsh
  • Chief Business Officer
  • --
  • Dr. Duane D. Nash, M.D.
  • Executive Chairman of the Board
  • 648.93K
  • Simona Skerjanec, M.B.A.
  • Director
  • --
  • Monika Maria Tornsen
  • Independent Director
  • 79.67K
  • Dr. Jorg Neermann, PhD
  • Independent Director
  • 82.95K
  • Richard Alan Rudick
  • Independent Director
  • 95.70K
  • Barclay A. Phillips
  • Lead Independent Director
  • 99.16K
  • Tamar D. Howson
  • Independent Director
  • 75.97K
  • Inderpal Singh
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data